Stem Cells Therapy
for
Autism

Regenerate. Repair. Restore.

Schedule Your Free Phone Consultation

If you are considering stem cell therapy, contact the Stem Cells Transplant Institute today

Autism is also referred to as ASD, or autism spectrum disorder. It is a mental health disorder that causes delayed neural development characterized by characteristic signs and symptoms, such as:

● Challenges with social skills
● Impaired social interactions (communication)
● Mood alterations
● Repetitive behavior
● Problems with memory, thinking, and speech

It may also cause a broad range of physical symptoms, such as digestive issues, and sleep disorders. According to statistical data from the CDC, an estimated 1 in 54 children in the US are suffering from autism today.

What Do We Know About Autism?

Autism is a congenital (by birth) neurological disorder that affects the information-formation and processing parts of the brain. Studies have shown that it alters the nerve cell connections and the way they are organized to process information. Conventional therapies (medical management / educational interventions) and drugs (psychoactive drugs or anticonvulsants) are not so effective when it comes to treating autism spectrum disorder.

Stem cell therapy is a safe and effective treatment approach for autism spectrum disorder. It is a completely new tool based on stem cell therapy to positively influence the nerve function, metabolism, ad immune system. It is also shown to help restore the damaged nerve cells and tissues. Studies have shown it to be effective for treating neurological conditions, including autism spectrum disorder.

Can Stem Cell Therapy Improve The Signs And Symptoms Of Autism?

Stem cell therapy treats ASD with umbilical cord tissue-derived mesenchymal stem cells (UCTMSCs). Clinical trials have shown that mesenchymal stromal cells (MSCs) decrease the severity of autism by stimulating activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC). The IV administration of these cells helps reduce neuro-inflammation and ease symptoms of autism spectrum disorder.

Based on our clinical practice, stem cell therapy help improve the following signs and symptoms of autism.

What is the recommended treatment protocol for autism at the Stem Cells Transplant Institute?

We don’t use autologous stem cells because most of the patients with autism are children. Instead, our company uses two sources (donated placenta and umbilical cord) to get a combination of allogenic mesenchymal stem cells (MCSs).

This is a non-invasive procedure to get a large number of high-quality MCSs – without doing a child’s own liposuction or bone marrow biopsy. Both sources of stem cells, umbilical cord, and placenta provide MCSs with strong therapeutic properties with reference to autism. We prepare these cell lines in our own laboratory and provide quality assurance and third-party testing.

What are the advantages of human umbilical cord mesenchymal stem cells?

You may be wondering the potential health advantages of human umbilical cord-derived MCSs. These cells have a greater proliferation ability and contain more liable cells (10 times more viabilty than cells derived from adipose tissue or bone marrow).

These cells have strong immunomodulatory as well as immunosuppressing properties that significantly reduce the chances of tissue rejection. Furthermore, their regeneration rate is higher compared to autologous adult stem cells, are less affected by environmental toxins, and resist aging process.

What are the advantages of human umbilical cord mesenchymal stem cells?

How are the stem cells collected?

Our company focuses on deriving high-quality stem cells exclusively from umbilical cord donations. We collect the placenta after the delivery of the baby is complete and with the parent/s informed consent. We also make sure to follow the strict ethical protocols and collect stem cells from reliable sources.

How are the stem cells administered?

Our nursing staff will give stem cells through an IV and intra-pulmonary route. Intravenous the administration is preferred to increase the effectiveness of the treatment.

About the Stem Cells Transplant Institute

We are based in Costa Rica – one of the best-known destinations for medical tourism – including stem cell therapy. At Stem Cells Transplant Institute, we have a qualified team of doctors and health experts to collect and administer stem cells for the treatment of autism and many other body conditions. Our dedicated team is committed to provide cost-effective and finest-quality service to every patient.

Scientific References:

  1. Fu et al. Stem cell transplantation therapy in Parkinson’s disease. SpringerPlus (2015) 4:597
  2. Joyce et al. Mesenchymal stem cell for the treatment of neurodegenerative disease. Regen Med. 2010, November, 5(6)933-946. Doi:10.2217/rme.10.72
  3. Helena Vilaça-Faria, António J. Salgado and Fábio G. Teixeira Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s disease. Cells20198(2), 118; doi:3390/cells8020118
  4. Teixeira, F.G.; Carvalho, M.M.; Neves-Carvalho, A.; Panchalingam, K.M.; Behie, L.A.; Pinto, L.; Sousa, N.; Salgado, A.J. Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. Stem Cell Rev.201511, 288–297. [Google Scholar] [CrossRef] [PubMed]
  5. Gao, F.; Chiu, S.M.; Motan, D.A.; Zhang, Z.; Chen, L.; Ji, H.L.; Tse, H.F.; Fu, Q.L.; Lian, Q. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis.20167, e2062. [Google Scholar] [CrossRef] [PubMed]
  6. Joyce, N.; Annett, G.; Wirthlin, L.; Olson, S.; Bauer, G.; Nolta, J.A. Mesenchymal stem cells for the treatment of neurodegenerative disease.  Med.20105, 933–946. [Google Scholar] [CrossRef] [PubMed]
  7. Fraga, J.S.; Silva, N.A.; Lourenco, A.S.; Goncalves, V.; Neves, N.M.; Reis, R.L.; Rodrigues, A.J.; Manadas, B.; Sousa, N.; Salgado, A.J. Unveiling the effects of the secretome of mesenchymal progenitors from the umbilical cord in different neuronal cell populations. Biochimie201395, 2297–2303. [Google Scholar] [CrossRef] [PubMed]
  8. Ribeiro, C.A.; Fraga, J.S.; Graos, M.; Neves, N.M.; Reis, R.L.; Gimble, J.M.; Sousa, N.; Salgado, A.J. The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Res. Ther.20123, 18. [Google Scholar] [CrossRef]
  9. Ribeiro, C.A.; Salgado, A.J.; Fraga, J.S.; Silva, N.A.; Reis, R.L.; Sousa, N. The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures).  Tissue Eng. Regen. Med.20115, 668–672. [Google Scholar] [CrossRef]
  10. Salgado, A.J.; Fraga, J.S.; Mesquita, A.R.; Neves, N.M.; Reis, R.L.; Sousa, N. Role of human umbilical cord mesenchymal progenitors conditioned media in neuronal/glial cell densities, viability, and proliferation. Stem Cells Dev.201019, 1067–1074. [Google Scholar] [CrossRef]
  11. Martins, L.F.; Costa, R.O.; Pedro, J.R.; Aguiar, P.; Serra, S.C.; Teixeira, F.G.; Sousa, N.; Salgado, A.J.; Almeida, R.D. Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF.  Rep.20177, 4153. [Google Scholar] [CrossRef]
  12. Serra, S.C.; Costa, J.C.; Assuncao-Silva, R.C.; Teixeira, F.G.; Silva, N.A.; Anjo, S.I.; Manadas, B.; Gimble, J.M.; Behie, L.A.; Salgado, A.J. Influence of passage number on the impact of the secretome of adipose tissue stem cells on neural survival, neurodifferentiation and axonal growth. Biochimie2018155, 119–128. [Google Scholar] [CrossRef]
  13. Assuncao-Silva, R.C.; Mendes-Pinheiro, B.; Patricio, P.; Behie, L.A.; Teixeira, F.G.; Pinto, L.; Salgado, A.J. Exploiting the impact of the secretome of MSCs isolated from different tissue sources on neuronal differentiation and axonal growth. Biochimie2018155, 83–91. [Google Scholar] [CrossRef] [PubMed]